Profound Medical (TSE:PRN) Shares Up 2.7%

Profound Medical Corp. (TSE:PRN)’s share price shot up 2.7% during trading on Friday . The company traded as high as C$15.64 and last traded at C$15.40. 12,696 shares traded hands during mid-day trading, an increase of 110% from the average session volume of 6,040 shares. The stock had previously closed at C$15.00.

Profound Medical Stock Performance

The firm’s 50-day simple moving average is C$11.85 and its two-hundred day simple moving average is C$11.38. The company has a current ratio of 5.41, a quick ratio of 14.98 and a debt-to-equity ratio of 15.78. The stock has a market capitalization of C$376.22 million, a PE ratio of -8.75 and a beta of 1.27.

Profound Medical (TSE:PRN) last posted its quarterly earnings results on Thursday, May 9th. The company reported C($0.35) earnings per share for the quarter, beating the consensus estimate of C($0.41) by C$0.06. The business had revenue of C$2.58 million for the quarter, compared to analyst estimates of C$3.24 million. On average, equities research analysts expect that Profound Medical Corp. will post -1.9000001 earnings per share for the current fiscal year.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.